Cargando…
Immunotherapy after liver transplantation: Where are we now?
BACKGROUND: There is limited evidence on the safety of immunotherapy use after liver transplantation and its efficacy in treating post-liver transplant hepatocellular carcinoma (HCC) recurrence. AIM: To assess the safety of immunotherapy after liver transplant and its efficacy in treating post-liver...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554723/ https://www.ncbi.nlm.nih.gov/pubmed/34754394 http://dx.doi.org/10.4240/wjgs.v13.i10.1267 |